We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.59B
AUM Growth
+$283M
Cap. Flow
+$228M
Cap. Flow %
14.35%
Top 10 Hldgs %
6.1%
Holding
1,532
New
540
Increased
294
Reduced
266
Closed
432

Top Buys

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$11.9M
2
BMO icon
Bank of Montreal
BMO
+$10.5M
3
HPQ icon
HP
HPQ
+$9.75M
4
AER icon
AerCap
AER
+$9.53M
5
ITW icon
Illinois Tool Works
ITW
+$8.27M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$8.73M
2
SYF icon
Synchrony
SYF
+$8.42M
3
CAH icon
Cardinal Health
CAH
+$7.63M
4
BRO icon
Brown & Brown
BRO
+$7.55M
5
UL icon
Unilever
UL
+$7.37M

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Financials 17.36%
3 Industrials 17.08%
4 Consumer Discretionary 12.43%
5 Healthcare 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AA icon
1101
Alcoa
AA
$13.5B
-15,114
Closed -$461K
A icon
1102
Agilent Technologies
A
$41.9B
-22,115
Closed -$2.59M
AAL icon
1103
American Airlines Group
AAL
$9.88B
-435,409
Closed -$4.59M
AAT
1104
American Assets Trust
AAT
$1.39B
-25,841
Closed -$520K
ABBV icon
1105
AbbVie
ABBV
$440B
-34,587
Closed -$7.25M
ABCB icon
1106
Ameris Bancorp
ABCB
$5.94B
-8,438
Closed -$486K
ABT icon
1107
Abbott
ABT
$192B
-8,142
Closed -$1.08M
ADI icon
1108
Analog Devices
ADI
$187B
-4,863
Closed -$981K
ADMA icon
1109
ADMA Biologics
ADMA
$2.19B
-89,844
Closed -$1.78M
ADNT icon
1110
Adient
ADNT
$1.44B
-129,505
Closed -$1.67M
ADSK icon
1111
Autodesk
ADSK
$52.7B
-3,466
Closed -$907K
ADUS icon
1112
Addus HomeCare
ADUS
$2.2B
-28,970
Closed -$2.86M
AFG icon
1113
American Financial Group
AFG
$12B
-11,118
Closed -$1.46M
AG icon
1114
First Majestic Silver
AG
$9.44B
-43,003
Closed -$288K
AGNC icon
1115
AGNC Investment
AGNC
$12.9B
-220,620
Closed -$2.11M
AGYS icon
1116
Agilysys
AGYS
$3.03B
-4,972
Closed -$361K
ALC icon
1117
Alcon
ALC
$35.6B
-5,664
Closed -$535K
ALGT icon
1118
Allegiant Air
ALGT
$2.31B
-86,411
Closed -$4.46M
ALL icon
1119
Allstate
ALL
$64.7B
-2,158
Closed -$447K
AMGN icon
1120
Amgen
AMGN
$225B
-13,861
Closed -$4.32M
ANDE icon
1121
Andersons Inc
ANDE
$2.23B
-26,088
Closed -$1.12M
ANF icon
1122
Abercrombie & Fitch
ANF
$4.99B
-35,646
Closed -$2.72M
AON icon
1123
Aon
AON
$74.7B
-5,514
Closed -$2.2M
APEI icon
1124
American Public Education
APEI
$826M
-18,053
Closed -$403K
APT icon
1125
Alpha Pro Tech
APT
$54.8M
-12,242
Closed -$61.2K

Similar funds

Campbell & Co Investment Adviser's Q2 2025 Portfolio in Review

As of Q2 2025, Campbell & Co Investment Adviser held 1,532 positions worth $1.59B, up 22% from $1.3B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Campbell & Co Investment Adviser deployed $228M of net new capital in Q2 2025, opening 540 new positions and adding to 294 existing holdings. Its largest new stake was Johnson Controls International: 128,951 shares worth $13.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 9.9% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cardinal Health, an estimated $7.63M trimmed.

  • Campbell & Co Investment Adviser's largest Q2 2025 buy was Johnson Controls International: 128,951 shares worth $13.6M.
  • Campbell & Co Investment Adviser added most to Dover in Q2 2025, an estimated $7.63M increase.
  • Campbell & Co Investment Adviser's biggest Q2 2025 reduction was Cardinal Health, cutting an estimated $7.63M.
  • Campbell & Co Investment Adviser fully exited Labcorp in Q2 2025, selling an estimated $8.73M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6.1% of its $1.59B portfolio in Q2 2025.
  • Campbell & Co Investment Adviser opened 540 new positions and closed 432 in Q2 2025.
  • Campbell & Co Investment Adviser's portfolio value rose 22% quarter-over-quarter to $1.59B.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2025, filed 7 Aug 2025.